ht7800 (Hitachi Ltd)
Hitachi Ltd is a verified supplier 
Hitachi Ltd manufactures this product 
99
Structured Review
Hitachi Ltd
ht7800
Ht7800, supplied by Hitachi Ltd, used in various techniques. Bioz Stars score: 99/100, based on 50559 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ht7800/HT7800/custom%40ht7800%4042633398
Average 99 stars, based on 50559 article reviews
Ht7800, supplied by Hitachi Ltd, used in various techniques. Bioz Stars score: 99/100, based on 50559 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ht7800/HT7800/custom%40ht7800%4042633398
Average 99 stars, based on 50559 article reviews
ht7800 - by Bioz Stars,
2026-09
99/100 stars
Images
Related Articles
Transmission Electron Microscopy:Article Title: Therapeutic potential and underlying mechanisms of engineered young plasma-derived exosomes in Alzheimer's disease Article Snippet: ive, post-fixed with 1% osmium tetroxide, dehydrated, and embedded in 812 resin. Ultrathin sections (60–80 nm thickness) were prepared, stained with uranyl acetate and lead citrate, and imaged using a Software:Article Title: Therapeutic potential and underlying mechanisms of engineered young plasma-derived exosomes in Alzheimer's disease Article Snippet: ive, post-fixed with 1% osmium tetroxide, dehydrated, and embedded in 812 resin. Ultrathin sections (60–80 nm thickness) were prepared, stained with uranyl acetate and lead citrate, and imaged using a Staining:Article Title: Therapeutic potential and underlying mechanisms of engineered young plasma-derived exosomes in Alzheimer's disease Article Snippet: ive, post-fixed with 1% osmium tetroxide, dehydrated, and embedded in 812 resin. Ultrathin sections (60–80 nm thickness) were prepared, stained with uranyl acetate and lead citrate, and imaged using a Spectrophotometry:Article Title: Therapeutic potential and underlying mechanisms of engineered young plasma-derived exosomes in Alzheimer's disease Article Snippet: ive, post-fixed with 1% osmium tetroxide, dehydrated, and embedded in 812 resin. Ultrathin sections (60–80 nm thickness) were prepared, stained with uranyl acetate and lead citrate, and imaged using a Microscopy:Article Title: Therapeutic potential and underlying mechanisms of engineered young plasma-derived exosomes in Alzheimer's disease Article Snippet: ive, post-fixed with 1% osmium tetroxide, dehydrated, and embedded in 812 resin. Ultrathin sections (60–80 nm thickness) were prepared, stained with uranyl acetate and lead citrate, and imaged using a Transmission Assay:Article Title: Therapeutic potential and underlying mechanisms of engineered young plasma-derived exosomes in Alzheimer's disease Article Snippet: ive, post-fixed with 1% osmium tetroxide, dehydrated, and embedded in 812 resin. Ultrathin sections (60–80 nm thickness) were prepared, stained with uranyl acetate and lead citrate, and imaged using a Electron Microscopy:Article Title: Therapeutic potential and underlying mechanisms of engineered young plasma-derived exosomes in Alzheimer's disease Article Snippet: ive, post-fixed with 1% osmium tetroxide, dehydrated, and embedded in 812 resin. Ultrathin sections (60–80 nm thickness) were prepared, stained with uranyl acetate and lead citrate, and imaged using a Encapsulation:Article Title: Therapeutic potential and underlying mechanisms of engineered young plasma-derived exosomes in Alzheimer's disease Article Snippet: ive, post-fixed with 1% osmium tetroxide, dehydrated, and embedded in 812 resin. Ultrathin sections (60–80 nm thickness) were prepared, stained with uranyl acetate and lead citrate, and imaged using a Zeta Potential Analyzer:Article Title: Therapeutic potential and underlying mechanisms of engineered young plasma-derived exosomes in Alzheimer's disease Article Snippet: ive, post-fixed with 1% osmium tetroxide, dehydrated, and embedded in 812 resin. Ultrathin sections (60–80 nm thickness) were prepared, stained with uranyl acetate and lead citrate, and imaged using a High Performance Liquid Chromatography:Article Title: Therapeutic potential and underlying mechanisms of engineered young plasma-derived exosomes in Alzheimer's disease Article Snippet: ive, post-fixed with 1% osmium tetroxide, dehydrated, and embedded in 812 resin. Ultrathin sections (60–80 nm thickness) were prepared, stained with uranyl acetate and lead citrate, and imaged using a Chromatography:Article Title: Therapeutic potential and underlying mechanisms of engineered young plasma-derived exosomes in Alzheimer's disease Article Snippet: ive, post-fixed with 1% osmium tetroxide, dehydrated, and embedded in 812 resin. Ultrathin sections (60–80 nm thickness) were prepared, stained with uranyl acetate and lead citrate, and imaged using a Liquid Chromatography:Article Title: Therapeutic potential and underlying mechanisms of engineered young plasma-derived exosomes in Alzheimer's disease Article Snippet: ive, post-fixed with 1% osmium tetroxide, dehydrated, and embedded in 812 resin. Ultrathin sections (60–80 nm thickness) were prepared, stained with uranyl acetate and lead citrate, and imaged using a Conjugation Assay:Article Title: Therapeutic potential and underlying mechanisms of engineered young plasma-derived exosomes in Alzheimer's disease Article Snippet: ive, post-fixed with 1% osmium tetroxide, dehydrated, and embedded in 812 resin. Ultrathin sections (60–80 nm thickness) were prepared, stained with uranyl acetate and lead citrate, and imaged using a Light Microscopy:Article Title: Therapeutic potential and underlying mechanisms of engineered young plasma-derived exosomes in Alzheimer's disease Article Snippet: ive, post-fixed with 1% osmium tetroxide, dehydrated, and embedded in 812 resin. Ultrathin sections (60–80 nm thickness) were prepared, stained with uranyl acetate and lead citrate, and imaged using a Extraction:Article Title: Therapeutic potential and underlying mechanisms of engineered young plasma-derived exosomes in Alzheimer's disease Article Snippet: ive, post-fixed with 1% osmium tetroxide, dehydrated, and embedded in 812 resin. Ultrathin sections (60–80 nm thickness) were prepared, stained with uranyl acetate and lead citrate, and imaged using a RNA Extraction:Article Title: Therapeutic potential and underlying mechanisms of engineered young plasma-derived exosomes in Alzheimer's disease Article Snippet: ive, post-fixed with 1% osmium tetroxide, dehydrated, and embedded in 812 resin. Ultrathin sections (60–80 nm thickness) were prepared, stained with uranyl acetate and lead citrate, and imaged using a Isolation:Article Title: Therapeutic potential and underlying mechanisms of engineered young plasma-derived exosomes in Alzheimer's disease Article Snippet: ive, post-fixed with 1% osmium tetroxide, dehydrated, and embedded in 812 resin. Ultrathin sections (60–80 nm thickness) were prepared, stained with uranyl acetate and lead citrate, and imaged using a Reverse Transcription:Article Title: Therapeutic potential and underlying mechanisms of engineered young plasma-derived exosomes in Alzheimer's disease Article Snippet: ive, post-fixed with 1% osmium tetroxide, dehydrated, and embedded in 812 resin. Ultrathin sections (60–80 nm thickness) were prepared, stained with uranyl acetate and lead citrate, and imaged using a Fluorescence:Article Title: Therapeutic potential and underlying mechanisms of engineered young plasma-derived exosomes in Alzheimer's disease Article Snippet: ive, post-fixed with 1% osmium tetroxide, dehydrated, and embedded in 812 resin. Ultrathin sections (60–80 nm thickness) were prepared, stained with uranyl acetate and lead citrate, and imaged using a Immunofluorescence:Article Title: Therapeutic potential and underlying mechanisms of engineered young plasma-derived exosomes in Alzheimer's disease Article Snippet: ive, post-fixed with 1% osmium tetroxide, dehydrated, and embedded in 812 resin. Ultrathin sections (60–80 nm thickness) were prepared, stained with uranyl acetate and lead citrate, and imaged using a |